Yann Echelard's most recent trade in TG Therapeutics Inc was a trade of 14,718 Common Stock done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc | Yann Echelard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 14,718 | 238,816 (0%) | 0% | 0 | Common Stock | |
| TG Therapeutics Inc | Yann Echelard | Director | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 12 Jun 2025 | 10,000 | 228,816 (0%) | 0% | 36.9 | 369,400 | Common Stock |
| TG Therapeutics Inc | Yann Echelard | Director | Sale of securities on an exchange or to another person at price $ 24.48 per share. | 05 Nov 2024 | 20,000 | 224,098 (0%) | 0% | 24.5 | 489,600 | Common Stock |
| TG Therapeutics Inc | Yann Echelard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 22,250 | 244,098 (0%) | 0% | 0 | Common Stock | |
| TG Therapeutics Inc | Yann Echelard | Director | Purchase of securities on an exchange or from another person at price $ 10.64 per share. | 06 Jan 2023 | 9,000 | 201,848 (0%) | 0% | 10.6 | 95,760 | Common Stock |
| TG Therapeutics Inc | Yann Echelard | Director | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 10 Dec 2020 | 30,000 | 129,116 (0%) | 0% | 40.1 | 1,201,500 | COMMON STOCK |